Advances in Inflammatory Bowel Diseases is dedicated to the interests of the entire community of IBD patients and is designed to meet the educational needs of all healthcare professionals who treat and manage patients with inflammatory bowel diseases.
We believe the growth and success of Advances in IBD comes from our dedication to offering a comprehensive scientific agenda that is clinically relevant, scientifically state of the art, and the most effective in addressing the educational needs of attendees, while always remaining focused on the goal of enhancing the lives of patients with inflammatory bowel diseases.
Program
Session IA The Evolution of IBD Clinical Practice After 20 Years
Session IIA IBD Issues Beyond the Intestine
Session IIIA Clinical Breakout Session A Approach to the Prevention and Management of Neoplasia in IBD
Session IIIA Clinical Breakout Session B Implications of Bariatrics in IBD
Session IIIA Clinical Breakout Session C What to Do When You’re Off Target
Session IIIA Clinical Breakout Session D Understanding Methodology for Clinical Practice
Session IIIA Clinical Breakout Session E #MedEd Workshop Social Media Strategy
Session IIIB Crohn’s Disease of Terminal Ileum With Penetrating Behavior
Session IIIC Innovations and Approaches in IBD Care for Children With IBD
Session IVA Special Considerations for the Healthcare System An Evolving IBD Landscape
Session IXA 2021 Editor’s Focus
Session VA International Perspectives on IBD
Session VIA Challenges in Clinical Practice
Session VIIA Novel Approaches to IBD Care
Session VIIIA Clinical Breakout Session A The Atypicals You See Every Day in Your Practice
Session VIIIA Clinical Breakout Session C IBD Flares in Pregnancy
Session VIIIA Clinical Breakout Session D Acute Severe UC Patient How Many Rescue Attempts
Session VIIIA Clinical Breakout Session E Applying High-Impact Publications to Your Practice
Session VIIIB Challenging Case Scenarios
Session VIIIC Innovations and Approaches in IBD Care for Children With IBD
Session VIIID APP Growth, Impact, and Role in Multidisciplinary IBD Care
Session XA Medical-Surgical Collaborative Decision-Making
Session XIA Multidisciplinary Care Over Two Decades
A Closer Look at Oral Selective Sphingosine 1-Phosphate Receptor Modulators
Expanding Choices in Ulcerative Colitis Treatment
A Whole New World In Inflammatory Bowel Disease Embracing Novel Horizons With Intravenous Iron
Advances in the Management of Fistulizing Crohn’s Disease
Anti-Cytokine Therapy in IBD A Closer Look at IL-12/23 and IL-23 Inhibitors
C. Difficile Infection and Recurrence Updated Treatment Strategies for Patients with Inflammatory Bowel Disease
Clinical Consistency
Evolution Towards Precision-Guided Dosing
Overview of a Once-Daily Oral S1P Receptor for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adults
